| Literature DB >> 35941326 |
Ziang Yang1, Bei Xu2, Sheng Wu3, Weige Yang1, Rongkui Luo4, Shengkai Geng5, Zhaochen Xin1, Wen Jin2, Xiong Shen6, Xixi Gu7, Hongwei Zhang1, Hong Wang8.
Abstract
Mesenchymal stromal cells (MSCs) play an important role in the development of human cancer. Meanwhile, exosomes released by MSCs can mediate cell-cell communication by delivering microRNAs (miRNAs/miRs). Hence, this study aimed to explore the role of bone marrow mesenchymal stromal cell (BMSC)-derived exosomal miR-551b-3p in breast cancer. In this study, we found that upregulation of miR-551b-5p suppressed the proliferation and migration and induced the apoptosis of breast cancer cells via downregulating tripartite motif-containing protein 31 (TRIM31). In addition, miR-551b-5p could be transferred from BMSCs to breast cancer cells via exosomes; BMSC-derived exosomal miR-551b-3p suppressed the proliferation and migration and promoted the apoptosis and oxidative stress of MDA-MB-231 cells via inhibiting TRIM31. Furthermore, a xenograft mouse model was used to explore the role of BMSC-derived exosomal miR-551b-3p in vivo. We found that BMSC-derived exosomal miR-551b-3p inhibited tumor growth in a mouse xenograft model of breast cancer in vivo. Collectively, these findings indicated that BMSC-derived exosomal miR-551b-3p could suppress the development of breast cancer via downregulating TRIM31. Thus, miR-551b-3p could serve as a potential target for the treatment of breast cancer.Entities:
Keywords: Bone marrow mesenchymal stromal cells; Breast cancer; Exosome; Proliferation; microRNAs
Mesh:
Substances:
Year: 2022 PMID: 35941326 DOI: 10.1007/s13577-022-00753-x
Source DB: PubMed Journal: Hum Cell ISSN: 0914-7470 Impact factor: 4.374